Description
NSC668394 is a potent ezrin (Thr567) phosphorylation inhibitor, with a Kd of 12.59 μM. NSC668394 inhibit ezrin T567 phosphorylation caused by PKCΙ primarily via their binding to ezrin. NSC668394 can be used to prevent tumor metastasis.
Product information
CAS Number: 382605-72-3
Molecular Weight: 452.10
Formula: C17H12Br2N2O3
Chemical Name: 7-{[2-(3,5-dibromo-4-hydroxyphenyl)ethyl]amino}-5,8-dihydroquinoline-5,8-dione
Smiles: OC1=C(Br)C=C(CCNC2=CC(=O)C3=CC=CN=C3C2=O)C=C1Br
InChiKey: OHPHDPYJEHZGDE-UHFFFAOYSA-N
InChi: InChI=1S/C17H12Br2N2O3/c18-11-6-9(7-12(19)16(11)23)3-5-20-13-8-14(22)10-2-1-4-21-15(10)17(13)24/h1-2,4,6-8,20,23H,3,5H2
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
How to use
In Vitro:
NSC668394 (10 μM; pretreated for 15 min) inhibits ezrin T567 phosphorylation (IC50=8.1 μM) and actin binding in vitro. NSC668394 (1-10 μM; 2-6 h) inhibits ezrin-mediated invasion by K7M2 osteosarcoma (OS) cells on the HUVEC monolayer. NSC668394 (20 μM) causes significant decrease in growth in JM1 and JM2 rat hepatoma cell lines. NSC668394 (10 μM) reduces cell motility phenotypes in zebrafish.
In Vivo:
NSC668394 (0.226 mg/kg/day; i.p. 5-days a week) inhibits ezrin-dependent in vivo OS metastatic growth in mouse lung.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.